Status:
COMPLETED
COVID19 Severity Prediction and Health Services Research Evaluation
Lead Sponsor:
Hospital Galdakao-Usansolo
Collaborating Sponsors:
Hospital Costa del Sol
Hospital del Mar
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
1\. Objectives: 1.-To create risk stratification scales of poor evolution in patients infected by SARS-CoV-2. 2.-Evaluate the accessibility and equity that these patients have had in the different car...
Detailed Description
Background: One of the fundamental problems of this epidemic is determined by the high percentage of SARS-CoV-2 infected patients who present rapid clinical deterioration that makes them need care in ...
Eligibility Criteria
Inclusion
- Positive COVID19 people in the Basque country
- Patients admitted (confirmed cases) by CoVid-19
Exclusion
- Pediatric population (for objective #1 only)
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
380000 Patients enrolled
Trial Details
Trial ID
NCT04463706
Start Date
June 1 2020
End Date
December 31 2022
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Galdakao-Usansolo
Galdakao, Bizkaia, Spain, 48960